Compare IMRX & FRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IMRX | FRPH |
|---|---|---|
| Founded | 2008 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 366.1M | 435.3M |
| IPO Year | 2021 | N/A |
| Metric | IMRX | FRPH |
|---|---|---|
| Price | $5.28 | $23.80 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $17.20 | N/A |
| AVG Volume (30 Days) | ★ 3.1M | 56.8K |
| Earning Date | 11-12-2025 | 03-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.24 |
| Revenue | N/A | ★ $33,049,999.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $97.66 |
| Revenue Growth | N/A | ★ 5.21 |
| 52 Week Low | $1.10 | $21.68 |
| 52 Week High | $10.08 | $31.99 |
| Indicator | IMRX | FRPH |
|---|---|---|
| Relative Strength Index (RSI) | 46.85 | 51.57 |
| Support Level | $4.35 | $23.42 |
| Resistance Level | $5.37 | $24.19 |
| Average True Range (ATR) | 0.58 | 0.51 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 27.93 | 45.14 |
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).